Abstract

AimsRecent local research examined mortality rates following admission to a dementia ward. We wanted to expand on this work and include other important health outcomes for patients admitted to our specialist in-patient dementia unit in the west of Scotland. This would provide a comprehensive overview of our in-patient population, aid service review and improve care. We hypothesised that patients admitted would be physically frail, have a significant mortality rate and would likely require long-term care post discharge.MethodThe clinical notes for each admission to the unit for one year were examined (total 62). We extracted data from a number of different areas such as demographics, mortality rates, discharge destination, readmission rates and prescribed medications.Result60% had an Alzheimer's/mixed dementia diagnosis. Average length of stay was 64 days. 62% were discharged to a care home (50% of this total had lived at home prior to admission), 18% to complex care and 20% to the community. 66% were prescribed an antipsychotic and the average number of medications was 8.4. 35% had a readmission under general medicine within a year of discharge. 19% died whilst an inpatient and a further 30% had died one year post-discharge (total one-year mortality of 44%).ConclusionPeople admitted to our dementia unit are physically frail, with only 20% returning to live in the community, 35% being readmitted to a general medical ward within a year of discharge and 44% dying during the admission or within a year of discharge. We need to bear these results in mind when considering if hospital admission is appropriate and ultimately further develop our skills in palliative and end of life care in order to provide those people admitted to our dementia unit (and those who remain at home) with the highest standard of care.

Highlights

  • Borderline Personality Disorder is common in psychiatric settings with a reported prevalence of 20%.As per NICE Guidance (CG 78), no medications have been found effective for the longer term treatment of personality difficulties.This audit was carried out to review if patients were offered psychiatric reviews to discuss the medications they are using, the effectiveness of these, and any potential side effects

  • To audit the current practice of pharmacological management of Borderline Personality Disorder with NICE Clinical guideline [CG78]: Borderline personality disorder: Objectives: 23 patient records were analysed in the last 18months with a diagnosis of EUPD to compare current practice against NICE clinical guidance. (2009) Standards: When prescribing

  • Antipsychotic drugs should not be used for medium, long term treatment

Read more

Summary

Introduction

Borderline Personality Disorder is common in psychiatric settings with a reported prevalence of 20%.As per NICE Guidance (CG 78), no medications have been found effective for the longer term treatment of personality difficulties.This audit was carried out to review if patients were offered psychiatric reviews to discuss the medications they are using, the effectiveness of these, and any potential side effects. Bethany Dudley1*, Shakina Bellam[1] and Andrew Lawrie2 1Monkwearmouth Hospital, Cumbria Northumberlnd Tyne, Wear NHS Foundation Trust and 2Monkwearmouth Hospital, Sunderland, Cumbria, Northumberland Tyne Wear NHS Foundation Trust *Corresponding author. To audit the current practice of pharmacological management of Borderline Personality Disorder with NICE Clinical guideline [CG78]: Borderline personality disorder: Objectives: 23 patient records were analysed in the last 18months with a diagnosis of EUPD to compare current practice against NICE clinical guidance. 3) Agree with the person the target symptoms, monitoring arrangements and anticipated duration of treatment.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call